IRONWOOD INVESTMENT MANAGEMENT LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 1127761
BOSTON, MA
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,339,497
+$339,907 QoQ
Shares Held
52,080
+0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#114
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IRONWOOD INVESTMENT MANAGEMENT LLC holds $13,113,875 across 6 Biotechnology names. DNLI ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
56,589 | $4,820,816 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
61,163 | $4,555,420 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
113,387 | $1,924,177 | |
| 4 | DNLI |
Denali Therapeutics Inc.
This page
|
52,080 | $1,339,497 | |
| 5 | REPL |
Replimune Group, Inc.
|
21,525 | $238,281 | |
| 6 | VALN |
Valneva SE
|
45,064 | $235,684 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,339,497 | 52,080 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $999,590 | 52,062 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $840,903 | 50,933 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $766,452 | 52,786 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $744,435 | 53,212 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $670,301 | 49,305 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $744,807 | 36,546 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,065,691 | 36,584 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $841,237 | 36,229 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $740,033 | 36,064 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $384,949 | 17,938 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $373,320 | 18,096 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $552,397 | 18,719 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $433,059 | 18,796 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $532,533 | 19,149 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $610,976 | 19,908 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $584,362 | 19,856 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $638,317 | 19,842 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $864,481 | 19,383 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $963,241 | 19,093 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,496,164 | 19,074 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,114,592 | 19,520 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,622,012 | 19,365 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $713,661 | 19,918 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $482,584 | 19,958 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $351,425 | 20,070 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||